logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Pulmonx Corporation


USPTO Granted Patents = 90


Trademarks = 9

Forward Citations = 2,753

Loading Chart...
Loading Chart...

55 inventors (with patents filed for the assignee):

goldMedal Ryan Olivera (28 out of 28 patents)

silverMedal Nikolai Aljuri (22 out of 83 patents)

bronzeMedal Peter P Soltesz (22 out of 22 patents)

4.  Rodney C Perkins (16 out of 90 patents)

5.  Srikanth Radhakrishnan (15 out of 15 patents)

6.  Robert Kotmel (15 out of 18 patents)

7.  Surag Mantri (13 out of 66 patents)

8.  Sri Radhakrishnan (13 out of 13 patents)

9.  Ajit Nair (11 out of 12 patents)

10.  Hoang Viet Nguyen (10 out of 34 patents)

11.  Niyazi Beyhan (9 out of 20 patents)

12.  Anthony D Wondka (9 out of 57 patents)

13.  Michael J Hendricksen (8 out of 91 patents)

14.  Rodney A Perkins (7 out of 7 patents)

15.  Antony Jonathan Fields (7 out of 43 patents)


Core Competencies:
Endobronchial Diagnostics
Lung Volume Reduction
Collateral Ventilation
Lung Imaging Data
Bronchial Isolation Devices
Lung Treatment Devices
Functional Assessment Catheters
Selective Lung Tissue Ablation
Residual Lung Volume Reduction
Sealant Delivery Methods
Pulmonary Occlusal Stent
Lung Disease Progression

90 patents:

1. 12508117 - Devices and systems for lung treatment (2025-12-30),
2. 12471800 - Systems and methods for endobronchial diagnostics (2025-11-18),
3. 12465249 - Methods and systems for endobronchial diagnostics (2025-11-11),
4. 12364412 - Methods and systems for endobronchial diagnosis (2025-07-22),
5. 12350428 - Methods and devices for passive residual lung volume reduction and functional lung volume expansion (2025-07-08),
6. 12310594 - Collateral flow channel sealant delivery methods and systems (2025-05-27),
7. 12064331 - Implant loading device and system (2024-08-20),
8. 12033320 - Methods, systems, and devices for analyzing lung imaging data to determine collateral ventilation (2024-07-09),
9. 12029637 - Devices and systems for lung treatment (2024-07-09),
10. 12004892 - Methods, systems, and devices for analyzing lung imaging data (2024-06-11),
11. 11937913 - Measuring lung function and lung disease progression at a lobar/segmental level (2024-03-26),
12. 11931170 - Functional assessment and treatment catheters and methods for their use in the lung (2024-03-19),
13. 11911145 - Methods and systems for determining collateral ventilation (2024-02-27),
14. 11883029 - Methods and devices for passive residual lung volume reduction and functional lung volume expansion (2024-01-30),
15. 11857406 - High resistance implanted bronchial isolation devices and methods (2024-01-02),
Pulmonx Corporation is a medical device company that develops minimally invasive solutions for patients with severe emphysema. Their groundbreaking Zephyr Endobronchial Valve (EBV) treatment helps to improve lung function and quality of life for patients suffering from this progressive and debilitating disease. With over a decade of clinical research and experience, Pulmonx is dedicated to providing innovative and effective solutions for emphysema patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
90 Patents

#19 in Redwood City, CA

#957 in California

#4,003 in US

#8,258 in the World

...
Redwood City, CA, United States of America

Pulmonx Corporation

Forward Citations = 2,753

55 inventors:

goldMedal Ryan Olivera (28 out of 28 patents)

silverMedal Nikolai Aljuri (22 out of 83 patents)

bronzeMedal Peter P Soltesz (22 out of 22 patents)

4.  Rodney C Perkins (16 out of 90 patents)

5.  Srikanth Radhakrishnan (15 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…